Table 3.
Correlation between SNRPD1 expression and clinical outcomes in HCC patients (n=154).
Characteristics | N | SNRPD1 level | X2 | *P-Value | ||
---|---|---|---|---|---|---|
high(n) | low(n) | |||||
Age (year) | >55 | 101 | 55 | 46 | 3.889 | 0.049 |
<=55 | 53 | 20 | 33 | |||
Gender | Male | 134 | 66 | 68 | 0.126 | 0.723 |
Female | 20 | 9 | 11 | |||
Tumor size (cm) | >5cm | 82 | 37 | 45 | 0.889 | 0.343 |
<=5cm | 72 | 38 | 34 | |||
TNM staging | I/II | 103 | 39 | 57 | 6.655 | 0.010 |
III | 51 | 36 | 22 | |||
Serum AFP level | >400ng/ml | 81 | 50 | 31 | 11.607 | 0.001 |
<=400ng/ml | 73 | 25 | 48 | |||
Tumor location | Left | 52 | 21 | 31 | 2.174 | 0.140 |
Right | 102 | 54 | 48 | |||
Tumor differentiation | Low | 20 | 14 | 6 | 12.472 | 0.002 |
Median | 98 | 52 | 46 | |||
High | 36 | 9 | 27 | |||
Vascular invasion | Yes | 73 | 44 | 29 | 7.440 | 0.006 |
No | 81 | 31 | 50 | |||
Tumor encapsulation | Yes | 104 | 50 | 54 | 0.050 | 0.823 |
No | 50 | 25 | 25 | |||
HBV DNA load | >104 | 72 | 38 | 33 | 1.225 | 0.268 |
<=104 | 82 | 37 | 46 | |||
Recurrence | Yes | 78 | 44 | 34 | 4.393 | 0.036 |
No | 76 | 31 | 45 | |||
Survival | Alive | 94 | 39 | 55 | 5.023 | 0.025 |
Dead | 60 | 36 | 24 |